224 related articles for article (PubMed ID: 35563611)
1. Rationale for 1068 nm Photobiomodulation Therapy (PBMT) as a Novel, Non-Invasive Treatment for COVID-19 and Other Coronaviruses: Roles of NO and Hsp70.
Kitchen LC; Berman M; Halper J; Chazot P
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563611
[TBL] [Abstract][Full Text] [Related]
2. A 57-Year-Old African American Man with Severe COVID-19 Pneumonia Who Responded to Supportive Photobiomodulation Therapy (PBMT): First Use of PBMT in COVID-19.
Sigman SA; Mokmeli S; Monici M; Vetrici MA
Am J Case Rep; 2020 Aug; 21():e926779. PubMed ID: 32865522
[TBL] [Abstract][Full Text] [Related]
3. The Effectiveness of Photobiomudulation Therapy (PBMT) in COVID-19 Infection.
Jahani Sherafat S; Mokmeli S; Rostami-Nejad M; Razaghi Z; Rezaei Tavirani M; Razzaghi M
J Lasers Med Sci; 2020; 11(Suppl 1):S23-S29. PubMed ID: 33995965
[No Abstract] [Full Text] [Related]
4. Photobiomodulation Therapy as a Possible New Approach in COVID-19: A Systematic Review.
de Matos BTL; Buchaim DV; Pomini KT; Barbalho SM; Guiguer EL; Reis CHB; Bueno CRS; Cunha MRD; Pereira ESBM; Buchaim RL
Life (Basel); 2021 Jun; 11(6):. PubMed ID: 34207199
[TBL] [Abstract][Full Text] [Related]
5. Photobiomodulation Treatment with a Home-Use Device for COVID-19: A Randomized Controlled Trial for Efficacy and Safety.
Lim L; Hosseinkhah N; Van Buskirk M; Berk A; Loheswaran G; Abbaspour Z; Karimpoor M; Smith A; Ho KF; Pushparaj A; Zahavi M; White A; Rubine J; Zidel B; Henderson C; Clayton RG; Tingley DR; Miller DJ; Karimpoor M; Hamblin MR
Photobiomodul Photomed Laser Surg; 2024 Jun; 42(6):393-403. PubMed ID: 38940733
[No Abstract] [Full Text] [Related]
6. Management of orofacial lesions with antimicrobial photodynamic therapy and photobiomodulation protocols in patients with COVID-19: A multicenter case series.
Sachet P; Rocha BA; Lima FS; Pedrosa MDS; Guollo A; Melo Filho MR; Horta MCR; Simões A
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102743. PubMed ID: 35101621
[TBL] [Abstract][Full Text] [Related]
7. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
8. Influence of photobiomodulation therapy on the treatment of pulmonary inflammatory conditions and its impact on COVID-19.
Macedo DB; Tim CR; Kido HW; Macedo JB; Martignago CCS; Renno ACM; Macedo GB; Assis L
Lasers Med Sci; 2022 Apr; 37(3):1921-1929. PubMed ID: 34694503
[TBL] [Abstract][Full Text] [Related]
9. COVID-19: from the structure and replication cycle of SARS-CoV-2 to its disease symptoms and treatment.
Zawilska JB; Lagodzinski A; Berezinska M
J Physiol Pharmacol; 2021 Aug; 72(4):. PubMed ID: 34987123
[TBL] [Abstract][Full Text] [Related]
10. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
Lupu L; Palmer A; Huber-Lang M
Front Immunol; 2020; 11():584514. PubMed ID: 33101314
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
12. Photobiomodulation therapy as a high potential treatment modality for COVID-19.
Soheilifar S; Fathi H; Naghdi N
Lasers Med Sci; 2021 Jul; 36(5):935-938. PubMed ID: 33241526
[TBL] [Abstract][Full Text] [Related]
13. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
Front Immunol; 2021; 12():589095. PubMed ID: 33995341
[TBL] [Abstract][Full Text] [Related]
14. Photobiomodulation and Antiviral Photodynamic Therapy in COVID-19 Management.
Fekrazad R; Asefi S; Pourhajibagher M; Vahdatinia F; Fekrazad S; Bahador A; Abrahamse H; Hamblin MR
Adv Exp Med Biol; 2021; 1318():517-547. PubMed ID: 33973198
[TBL] [Abstract][Full Text] [Related]
15. Blue photobiomodulation LED therapy impacts SARS-CoV-2 by limiting its replication in Vero cells.
Zupin L; Gratton R; Fontana F; Clemente L; Pascolo L; Ruscio M; Crovella S
J Biophotonics; 2021 Apr; 14(4):e202000496. PubMed ID: 33619888
[TBL] [Abstract][Full Text] [Related]
16. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
18. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
19. COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
Andreou A; Trantza S; Filippou D; Sipsas N; Tsiodras S
In Vivo; 2020 Jun; 34(3 Suppl):1567-1588. PubMed ID: 32503814
[TBL] [Abstract][Full Text] [Related]
20. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
Sasidharakurup H; Kumar G; Nair B; Diwakar S
OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
